As MYCN and ALK are risk indicators that are routinely examined in Chinese clinics, and TERT are found to be a novel risk factor in NB16,we evaluated MYCN,ALK and TERT levels in both the ALKBH5-low and ALKBH5-high groups and found that NB patients with higher ALKBH5 expression had lower MYCN, ALK and TERT levels (Figures 3A). The gene discussed is ALK; the disease is neuroblastoma.